245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA
Reports First Quarter 2026 Financial Results and Provides Business Updates
Financial Results, Press Release
Other Events
Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
News, Underwriting Agreement, Legal Opinion
Immuneering Announces Public Offering and Private Placement to Sanofi
Announces $25 Million Private Placement
Reports Second Quarter 2025 Financial Results and Provides Business Updates
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Submission Upload
Correspondence